Drugs / Active Immunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07551037 | Sep 2024 → Sep 2026 overdue | acute myeloid leukemia | Fujian Medical University Union Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Active Immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07551037 ↗ |
| Modality | Vaccine | “Personalized tumor vaccines are prepared from the patient's own acute myeloid leukemia (AML) cells” NCT07551037 ↗ |
| Route | Other | “administered via intradermal injection” NCT07551037 ↗ |